Institutional investors purchased a net $15.3 million shares of KERX during the quarter ended December 2015 and now own 69.88% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ABRAMS CAPITAL MANAGEMENT LP Bought 96.0 Thousand shares of Keryx Biopharmaceuticals ...
PURE FINANCIAL ADVISORS, INC. Bought 20.0 Thousand shares of Keryx Biopharmaceuticals ...